IDF2022-0602 Metformin or SGLT2 inhibitor as 1st line treatment of type 2 diabetes? Design and interim results of the SMARTEST trial

J. Eriksson, L. Bennet, B. Eliasson, J. Leksell,S. Jansson, R. Kristofi,M. Lundqvist,O. Östlund, J. Sundström

Diabetes Research and Clinical Practice(2023)

引用 0|浏览1
暂无评分
关键词
sglt2 inhibitor,metformin,diabetes,1st line treatment
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要